endometriosis
FDA Approves Relugolix for Endometriosis Pain
The FDA relugolix as a once-daily therapy for the management of moderate to severe pain associated with ...
AUGUST 24, 2022
FDA Grants sNDA Extension to Investigational Endometriosis Pain Drug
The FDA extended the review period for relugolix for the management of moderate to severe pain associated with ...
MAY 19, 2022
Researchers Urge Caution in Opioid Prescribing for Elective Gynecologic Procedures
One in every five women who underwent an elective gynecologic procedure had a new exposure to opioids, according to ...
MAY 14, 2021
ON PAIN: SCS Trial Shows Benefit for Chronic Pelvic Pain Patients
Causes of chronic pelvic pain can span different organ systems—genital, urinary or intestinal, for ...
MARCH 24, 2021
ON PAIN: Options Increasing for Endometriosis Diagnosis, Pain Treatment
There is a clinical need to improve the diagnosis of endometriosis, as well as expand its treatment armamentarium ...
JULY 9, 2020
ON PAIN: Pelvic Pain Can Persist Even With Standard Endometriosis Treatment
A variety of hormonal and surgical treatment options exist for the management of endometriosis-related pelvic pain, ...
JULY 2, 2020
Thinking Outside the Box to Combat Endometriosis Pain
National Harbor, Md.—“Chronic pain” is truly an umbrella term that describes diverging ...
JUNE 29, 2020
ON PAIN: Botulinum Toxin, From Food Poisoning to Pain Relief
Although today botulinum toxin is ubiquitous for treating frown lines and crow’s feet, even in the earliest ...
JUNE 25, 2020
ON PAIN: Botulinum Toxin Provides Relief for Endometriosis-Related Pelvic Pain
Botulinum toxin has been shown to do more than reduce wrinkles, especially when it comes to multiple chronic pain ...
JUNE 18, 2020
ON PAIN: Endometriosis, Widespread Yet Underdiagnosed
Although its formal definition is endometrium growing outside the uterus, attaching itself to the ovaries, ...
JUNE 11, 2020
FDA Approves Orilissa for Severe Endometriosis Pain
Orilissa is the first and only oral gonadotropin-releasing hormone antagonist specifically developed to treat women ...
JULY 31, 2018
